SEC Form 4 · accession 0001179110-15-006596
Theravance Biopharma, Inc. · TBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter S Ringrose
Director
Period of report
Apr 22, 2015
Accepted (ET)
Apr 24, 2015 · 7:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583107
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Apr 22, 2015 | A | 6,000 | $0.00 | A | 9,428 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes shares acquired in a pro rata distribution by Theravance, Inc.